4//SEC Filing
Spring Bank Pharmaceuticals, Inc. 4
Accession 0001209191-16-137099
CIK 0001566373operating
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 7:58 PM ET
Size
4.5 KB
Accession
0001209191-16-137099
Insider Transaction Report
Form 4
Afdhal Nezam H.
Chief Medical Officer
Transactions
- Purchase
Common Stock
2016-08-12$11.33/sh+2,600$29,450→ 33,850 total
Documents
Issuer
Spring Bank Pharmaceuticals, Inc.
CIK 0001566373
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001566373
Filing Metadata
- Form type
- 4
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 7:58 PM ET
- Size
- 4.5 KB